Facebook Twitter Youtube Linkedin
The Regulatory Review

Tag: Pharmaceuticals

FDA Seems Poised to Approve a New Drug for ALS, but Does it Work?

September 21, 2022• PPR Affiliates in the News

Read More →

FDA Still Skeptical of ALS Drug Ahead of High-Stakes Meeting

September 2, 2022• PPR Affiliates in the News

Holly Fernandez Lynch in WRAL, Sep 2, 2022...

Read More →

Subscribe to Updates

Contact Info

Penn Program on Regulation
University of Pennsylvania Carey Law School
3501 Sansom Street
Philadelphia, Pennsylvania 19104
regulation@law.upenn.edu

Program Director
Cary Coglianese
+1 215.898.6867

Links

Facebook Twitter Youtube Linkedin

Research Search

Site Map

Privacy Notice

The Regulatory Review
Penn Law

©2022 University of Pennsylvania Carey Law School

Site by Capital Technology Services